In this issue:
Deep learning for identifying HF subtypes
Achieving target RAS inhibitor doses in octogenarians with HFrEF
Associations of coronary microvascular dysfunction and cardiac maladaptation with HFpEF outcomes
Sex-specific risk factors for new-onset HF
Incident HF and recurrent coronary events after acute MI
Thoracentesis in acute HF
Guideline-directed medical therapy withdrawal in HF after EF improvement
Adverse pregnancy outcomes and long-term HF risk
Decongestion and outcomes in hospitalised acute HF
Macitentan for HF with EF ≥40% and pulmonary vascular disease
Please login below to download this issue (PDF)